Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W Michael Rogers


  • at Eyepoint Pharmaceuticals Inc. (EYPT), 2019-06-27
  • at Akebia Therapeutics Inc. (AKBA), 2019-06-10
  • See Remarks at Aerpio Pharmaceuticals Inc. (ARPO), 2019-05-16
  • Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
  • Chief Financial Officer at Acorda Therapeutics Inc (ACOR), 2016-05-13
  • Director at Coronado Biosciences Inc (CNDO), 2013-02-11
  • Evp, Cfo And Treasurer at Bg Medicine Inc. (BGMD), 2012-02-24
  • Officer at Indevus Pharmaceuticals Inc (IDEV), 2009-02-25
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACOR $38.06 964 Officer 40,713 2015-12-01 Filing
ACOR $30.45 4,433 Officer 41,677 2015-10-07 Filing
ACOR $29.52 1,267 Officer 46,110 2015-10-07 Filing
ACOR $35.58 230 Officer 41,505 2014-12-01 Filing
ACOR $33.10 5,700 Officer 41,735 2014-10-07 Filing